The eHealth Vietnam Summit 2020, taking place in Hanoi on December 29-30, will focus on providing an in-depth analysis and strategies for the digital transformation of the healthcare sector. The summit aims to bring together industry leaders and experts to discuss and explore the various approaches to transforming healthcare through digital technologies.

In light of the COVID-19 pandemic, remote healthcare consultation and support have emerged as vital resources. With travel restrictions in place and hospitals under immense pressure, this remote approach has become increasingly critical.

Revolutionizing healthcare in Vietnam for a brighter tomorrow

At [Company Name], we are committed to transforming the future of healthcare in Vietnam. Through our innovative solutions and dedicated team, we aim to revolutionize the way healthcare is delivered across the nation.

With a focus on cutting-edge technologies and advanced medical practices, our goal is to improve the quality of care, ensure accessibility for all, and empower individuals to take control of their health.

By partnering with leading healthcare providers and government agencies, we are driving positive change and shaping the future of the industry. Together, we aim to create a healthier and more prosperous Vietnam.

Vietnam’s successful containment of coronavirus outbreaks has garnered international praise. As part of the nation’s digital transformation program toward 2025, with a vision for 2030, Vietnam has established Telehealth. This network aims to connect approximately 14,000 health facilities nationwide and foster collaboration with other countries in the medical field.

According to a report shared on the Ministry of Health’s website in September, the newly established network will provide individuals across the country with the ability to remotely access medical services, receive consultations, and undergo treatment from doctors at more advanced hospitals. This innovative approach aims to alleviate patient overcrowding at central hospitals.

According to the Ministry of Health, as of late September 2020, the network has successfully linked 1,000 medical examination and treatment facilities with close to 30 major hospitals in Hanoi and Ho Chi Minh City.

The ministry implemented a mandate in late November, which made it obligatory for all hospitals nationwide to establish connectivity to a network for purposes of treatment, knowledge exchange, and professional development.

Abbott, a leading Chicago-based company with over 130 years of innovation, is actively responding to Vietnam’s growing demand for digital transformation. Committed to improving lives, Abbott has consistently introduced groundbreaking technologies and advancements in diagnostics, medical devices, medicines, and nutrition to Vietnam.

This demonstrates the company’s longstanding commitment as a strategic partner to shape the future of healthcare in Vietnam and the region.

Abbott has introduced Alinity, a revolutionary family of systems, to enhance speed, efficiency, and accuracy in patient diagnosis and treatment. By simplifying the diagnostic procedures, Alinity empowers diagnostic laboratories to deliver faster and more reliable results.

Alinity, an acronym for ALignment, INnovation, and UnITY, has been successfully implemented in a total of 18 hospitals and six blood banks. These include prestigious institutions such as Medic, Cho Ray Hospital, Tu Du Hospital, Hung Vuong Hospital, University Medical Center (under the University of Medicine and Pharmacy at Ho Chi Minh City), Da Nang General Hospital, DIAG, Hanoi Medical University Hospital, and the National Institute of Hematology and Blood Transfusion.

Abbott unveiled the Alinity m in 2020, a cutting-edge molecular diagnostics analyzer. This fully integrated and automated platform incorporates the latest technology to offer enhanced flexibility and efficiency.

Abbott’s Alinity m system

Abbott’s Alinity m system

The platform has expanded its availability to hospitals and healthcare facilities, such as Military Hospital 108, Medic, Medlatec, Bach Mai Hospital in Hanoi, and Cho Ray Hospital in Ho Chi Minh City.

Innovations Revolutionizing Vietnam’s Healthcare

Vietnam’s healthcare facilities are currently leveraging Abbott’s cutting-edge technology, diagnostic systems, and devices. These include the High-Sensitivity Troponin-I Test, DBS viral loading tests, and the revolutionary MitraClip device, developed to address common heart valve disorders and save lives.

The High-Sensitivity Troponin-I Test, also referred to as the Hs Troponin-I test, is designed to assess troponin levels, a protein exclusive to cardiac muscle cells.

The presence of a significant level of the macronutrient detected in the test yields more accurate predictive insights into an individual’s risk of developing heart disease in the future, when combined with the existing standard of care.

The test also provides gender-specific cut-offs, enabling physicians to accurately diagnose myocardial infarction, commonly referred to as heart attacks, in women.

According to a study published in the British Medical Journal, Abbott’s test has been shown to detect twice the number of heart attacks in women compared to standard troponin tests.

It is of utmost importance for medical professionals to promptly diagnose and respond to heart attacks. In Vietnam, the annual incidence of heart attacks is alarmingly high, with one out of every three individuals affected.

Abbott’s HS Troponin-I test has been granted approval by the Ministry of Health as the sole test available for aiding in cardiac risk stratification. This test is recognized for its significant impact and efficiency.

The test now caters to not only individuals at risk of heart disease but also to anyone seeking improved health management.

The Hs Troponin-I test serves a wider community, while the DBS test (dried blood spot test) facilitates access to HIV viral load testing for people in remote areas of Vietnam. This test is particularly beneficial as it is a simple procedure that does not require refrigeration.

The specimen consists of dried blood drops on a filter paper that is sent to a laboratory for analysis.

We have recently expanded our process to include HCV testing, which has proven to be highly efficient, especially during this challenging time of battling the pandemic.

Abbott is dedicated to driving advancements in heart and cardiovascular disease treatments. We are proud to introduce the MitraClip, a minimally invasive mitral valve repair device designed to assist individuals in Vietnam who are experiencing common heart valve disorders. This transcatheter-based device offers a cutting-edge solution to address these cardiovascular conditions. Our mission is to improve the health and well-being of the Vietnamese population by providing innovative and effective therapies for heart-related issues.

The MitraClip procedure is a minimally invasive technique in which medical professionals manipulate a slender tube through the patient’s vein to access the mitral valve. By promoting efficient closure without the need for open-heart surgery, this innovative approach allows for a quicker recovery time and facilitates a return to normal everyday activities for the patient.

Abbott’s MitraClip therapy was recognized as the Best Medical Technology for 2020 by Prix Galien USA in October. This award highlights the groundbreaking nature of the therapy.

The award is highly regarded in the industry and is seen as the biopharmaceutical and medical technology research equivalent of the Nobel Prize. It serves to honor and acknowledge exceptional scientific innovation that has a positive impact on humanity.

This innovative device has had a profound impact on over 100,000 individuals worldwide who suffer from mitral regurgitation, a condition characterized by a leaky heart valve.

Innovation for a better future of health.

With a presence in Vietnam for over 25 years, Abbott has consistently experienced substantial business growth, fostered the development of a highly skilled local workforce, and provided exceptional opportunities.

The company has been at the forefront of providing Vietnam with groundbreaking advancements in nutrition, pharmaceuticals, diagnostics, and medical devices.

Abbott’s nutrition business has introduced innovative products in Vietnam, including Similac Eye-Q Plus with HMO for enhancing babies’ immunity and brain development, PediaSure MRI with Arginine and natural vitamin K2 to support children’s growth and potential, and Ensure Gold with special nutritional ingredients to help elderly individuals maintain muscle and strength as they age.

Introducing Glucerna: Abbott’s latest reformulation designed to support individuals with diabetes. Emphasizing enhanced benefits, this newly arrived product aims to assist those managing their condition.

The new formulation of Glucerna offers dual therapeutic benefits, providing unique nutrients that promote GLP-1 secretion and improve insulin sensitivity. This results in better glycemic control for individuals.

Abbott has recently launched Surbex Natural Lingzhi, an innovative health support supplement available in capsule form. This scientifically backed product not only enhances liver function and overall body resistance, but also strengthens the immune system. With Surbex Natural Lingzhi, individuals can experience increased vitality and regain their ability to enjoy their favorite activities.

Abbott was recently recognized as the top company in the Pharma/Medical Equipment/Healthcare industry for the seventh consecutive year in the prestigious ‘Vietnam Best Places to Work 2020’ list.

Abbott’s consistent recognition in Vietnam for seven consecutive years underscores our leadership in the healthcare industry. We take pride in fostering an innovative and empowering culture that enables our employees to maximize their potential.

Abbott has showcased its enduring dedication to leveraging global expertise in order to advance healthcare in Vietnam over the past 25 years.

Abbott and its philanthropic arm, the Abbott Fund, have contributed over VND250 billion (US$10.5 million) in grants and product donations to tackle pressing healthcare challenges in Vietnam. With a specific emphasis on eliminating obstacles to attaining optimal health for the Vietnamese population and bolstering the nation’s healthcare industry, these contributions have made a significant impact.